Diabetes mellitus increases the susceptibility to encephalitozoonosis in mice

Aldo Francisco Neto1, Paulo Ricardo Dell'Armelina Rocha1, Elizabeth Christina Perez1

  • 1Programa de Patologia Ambiental e Experimental, Universidade Paulista (UNIP), São Paulo, Brasil.

Plos One
|November 2, 2017
PubMed

Insights

Diabetes and immunosuppression increase susceptibility to microsporidiosis, a fungal infection. Diabetic mice showed a weaker immune response and higher fungal burden, highlighting the need to consider microsporidiosis in diabetic patients.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Microbiology

Background:

  • Microsporidiosis is caused by opportunistic fungi affecting immunocompromised individuals.
  • Diabetes mellitus (DM) impairs immune function, increasing infection susceptibility.
  • Encephalitozoon cuniculi is a common microsporidian parasite.

Purpose of the Study:

  • To investigate the susceptibility of diabetic and/or immunosuppressed mice to Encephalitozoon cuniculi infection.
  • To evaluate the impact of diabetes and immunosuppression on immune responses and disease severity.

Main Methods:

  • Induction of type I diabetes using streptozotocin (STZ) in mice.
  • Experimental infection with Encephalitozoon cuniculi.
  • Assessment of immune cell populations (B lymphocytes, CD4+, CD8+ T lymphocytes, macrophages).
  • Measurement of cytokine levels (IL-6, TNF-α, IFN-γ).
  • Histopathological examination of organs (liver, lungs, kidneys).

Main Results:

  • STZ-induced diabetes suppressed B and CD4+ T lymphocyte populations.
  • Encephalitozoon cuniculi infection decreased CD4+, CD8+ T lymphocytes, and macrophages in diabetic mice.
  • Diabetic mice exhibited increased IL-6 and TNF-α, but not IFN-γ, levels.
  • Increased fungal burden and disease severity were observed in diabetic mice.
  • Combined diabetes and cyclophosphamide-induced immunosuppression exacerbated susceptibility.

Conclusions:

  • Diabetes mellitus compromises immune defenses, increasing susceptibility to microsporidiosis.
  • Microsporidiosis should be considered in the differential diagnosis of infections in diabetic patients.
  • The interplay between diabetes, immunosuppression, and opportunistic infections warrants further investigation.